This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
moving-average-crossover: Archive
Agenus (AGEN) Moves 82.7% Higher: Will This Strength Last?
by Zacks Equity Research
Agenus (AGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
AGENPositive Net Change RGENNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
American Well (AMWL) Soars 11.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
American Well (AMWL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AMWLNegative Net Change EVHNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Kronos Worldwide (KRO) Surges 9.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Kronos Worldwide (KRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
KROPositive Net Change SCLPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Oportun Financial (OPRT) Soars 6.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Oportun Financial (OPRT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
OPRTNegative Net Change FRSTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
GE Vernova (GEV) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
GEVNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Parker-Hannifin (PH) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
PHPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Sendas Distribuidora (ASAIY) Soars 6.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Sendas Distribuidora (ASAIY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ASAIYPositive Net Change REALPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
KB Financial (KB) Soars 6.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
KB Financial (KB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
KBPositive Net Change BBDPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Redwood Trust (RWT) Surges 7.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Redwood Trust (RWT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in FFO estimate revisions may not translate into further price increase in the near term.
RWTPositive Net Change ASPSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Should You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ABVXPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines